Skip to main content
. 2021 Nov 19;7:GO.21.00219. doi: 10.1200/GO.21.00219

FIG 1.

FIG 1

FIG 1

Cumulative OS rate (in months) between sex, histologic type of lung cancer, treatment, and patients' region regarding cancer and all-cause deaths. (A). Survival analysis by sex, cancer deaths. (B) Survival analysis by histologic cancer type, cancer deaths. (C) Survival analysis by patients' region, cancer deaths. (D) Survival analysis by treatment, all cancer deaths. (E) Survival analysis by sex, all-cause deaths. (F) Survival analysis by histologic cancer type, all-cause deaths. (G) Survival analysis by patients' region, all-cause deaths. (H) Survival analysis by treatment, all-cause deaths. NSCLC, non–small-cell lung cancer; OS, overall survival.